OA
OrbiMed Asia
OrbiMed Asia is a Series A to growth stage investment firm. It has made 10 investments. Average disclosed round size is $41.8M (across 8 rounds with reported amounts).
Portfolio
10
Fund Size
—
Top Stage
Unknown
Last 12 Mo
0
Team
DW
David Wang
Senior Managing Director
AB
Ankesh Bhansali
Managing Director, Private Equity
AS
Arun Sadhanandham
Managing Director, Private Equity
DZ
Daniel Zhou
Managing Director
JW
Jonathan Wang
Managing Director
WC
W. Carter Neild
Managing Director
JW
Jonathan W.
Founder, scientist, investor
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Kapiva | Unknown | $10M | Jan 2024 |
| EEpigenic Therapeutics | Series A | $32M | Aug 2023 |
| IInventisBio | Series D | $147M | Sep 2020 |
| ZZentera Therapeutics | Series A | — | Jan 2020 |
 Bonovo | Series C | $10M | Dec 2010 |
| BBonovo Orthopedics | Series C | $10M | Dec 2010 |
| UUquifa | Unknown | $42.5M | — |
| WWhale Imaging | Unknown | $8M | — |
 Iswarya Fertility | Growth | — | — |
 Zentera | Series B | $75M | — |
Top Co-Investors
OrbiMed6 shared
Legend Capital2 shared
Perceptive Advisors2 shared
Tybourne Capital Management2 shared
India Quotient2 shared
LAV2 shared
Morningside1 shared
Vertex Growth Fund1 shared
3one4 Capital1 shared
GL Ventures1 shared
MPC1 shared
Dyee Capital1 shared
Hillhouse Investment1 shared
Advantech Capital1 shared
Casdin Capital1 shared
Viking Global Investors1 shared
Logos Capital1 shared
Farallon Capital Management1 shared
Surveyor Capital1 shared
Redmile Group1 shared
Last updated: 20 October 2026